ambrisentan

ambrisentan
Trade Name Letairis
Orphan Indication Idiopathic pulmonary fibrosis
USA Market Approval USA
USA Designation Date 2009-12-23 00:00:00
Sponsor Gilead Sciences, Inc.;199 East Blaine Street;Seattle, Washington, 98102